
Alcedo to sell Nahrin SwissCare to Vam
Growth capital investor Alcedo is in advanced talks to sell supplements producer Nahrin SwissCare to Vam Investments, according to Mergermarket.
Vam takes stakes in businesses requiring restructurings, with a required investment of €5-20m.
The deal could complete in early 2021, Mergermarket reported, and involves the acquisition of a majority stake in the company.
The deal comes four years after Alcedo acquired a majority stake in Nahrin in September 2016, with the intention of accelerating the company's expansion plans. Alcedo IV, which closed on €195m in May 2016, acquired 55% of the business.
Founded in 1990 and headquartered in Villafranca di Verona, Nahrin produces cosmetics and vitamin-based nutritional supplements.
Vitale & Co and NCTM are respectively providing corporate finance and legal advice to Alcedo, according to Mergermarket sources.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater